PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth above 1.5x QCOM's 1.61%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
7.66%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
11.16%
EBIT growth above 1.5x QCOM's 2.06%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
10.84%
Operating income growth above 1.5x QCOM's 2.06%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
11.70%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
12.70%
EPS growth of 12.70% while QCOM is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
14.52%
Diluted EPS growth above 1.5x QCOM's 2.17%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-1.99%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.75%
Dividend reduction while QCOM stands at 13.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
134.52%
OCF growth above 1.5x QCOM's 19.92%. David Dodd would confirm a clear edge in underlying cash generation.
230.47%
FCF growth above 1.5x QCOM's 21.75%. David Dodd would verify if the firm’s strategic investments yield superior returns.
72.02%
10Y revenue/share CAGR under 50% of QCOM's 245.37%. Michael Burry would suspect a lasting competitive disadvantage.
42.89%
5Y revenue/share CAGR under 50% of QCOM's 99.75%. Michael Burry would suspect a significant competitive gap or product weakness.
22.19%
3Y revenue/share CAGR 1.25-1.5x QCOM's 19.32%. Bruce Berkowitz might see better product or regional expansions than the competitor.
292.55%
10Y OCF/share CAGR 1.25-1.5x QCOM's 261.09%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
19.41%
Below 50% of QCOM's 82.28%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
3.03%
Positive 3Y OCF/share CAGR while QCOM is negative. John Neff might see a big short-term edge in operational efficiency.
83.88%
Below 50% of QCOM's 351.50%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
86.72%
5Y net income/share CAGR above 1.5x QCOM's 37.30%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
32.48%
Positive short-term CAGR while QCOM is negative. John Neff would see a clear advantage in near-term profit trajectory.
16.38%
Below 50% of QCOM's 213.66%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
15.09%
Below 50% of QCOM's 90.82%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
7.05%
Below 50% of QCOM's 27.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
493.84%
Dividend/share CAGR of 493.84% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
784467.57%
5Y dividend/share CAGR above 1.5x QCOM's 110.72%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
50.12%
3Y dividend/share CAGR 1.25-1.5x QCOM's 35.37%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
2.27%
AR growth is negative/stable vs. QCOM's 17.35%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
5.56%
Inventory growth well above QCOM's 10.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.99%
Asset growth 1.25-1.5x QCOM's 3.17%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
4.19%
Positive BV/share change while QCOM is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
6.38%
R&D growth drastically higher vs. QCOM's 0.15%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.44%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.